Chokri Ben Lamine/X
Aug 10, 2026, 17:35
Chokri Ben Lamine: Balancing Holistic Care and Precision in Hematology
Chokri Ben Lamine, Assistant Consultant at King Faisal Specialist Hospital and Research Center, shared a post on LinkedIn:
“Holistic Approach vs. Micromanagement in Hematology
Holistic Hematologist
- Sees the whole patient, not just the CBC
- Prioritizes interventions by clinical impact
- Anticipates complications before they occur
- Coordinates with ICU, ID, Surgery, Pharmacy, Nursing
- Balances disease control with quality of life
- Delegates appropriately and empowers the team
Risks
- May overlook small but critical details if follow-up systems are weak
- Requires excellent communication and standardized protocols
Micromanagement
- Catches subtle abnormalities early
- Excellent for complex chemotherapy orders, CAR-T, HSCT, investigational protocols
- Reduces medication and documentation errors
Risks
- Decision fatigue
- Delays care (‘analysis paralysis’)
- Less autonomy for trainees and nurses
- Can miss the ‘big picture’ while chasing minor issues
Swiss Cheese Model in Hematology
Every safety layer has ‘holes’:
- Physician assessment
- Nursing checks
- Pharmacy verification
- Laboratory review
- Imaging
- EMR alerts
- Team handover
Checklists and protocols
- Harm occurs only when the holes align, allowing an error to pass through all defenses.
- The goal is NOT perfection by one person.
Build multiple independent safety barriers so one missed detail is caught by another layer.
The Best Hematologist
- Thinks holistically
- Reviews high-risk details meticulously
- Relies on robust systems, not memory alone
- Leads a multidisciplinary team rather than trying to do everything personally”
Other posts featuring Chokri Ben Lamine on Hemostasis Today.
-
Nov 8, 2026, 19:31Anna Kajaste-Rudnitski: Presenting AAV-Induced p53 Signalling in Human CNS Cells at ESGCT 26
-
Nov 8, 2026, 19:29David McIntosh: Cybersecurity Matters, but Blood Availability Remains the Bigger Challenge
-
Nov 8, 2026, 19:26Wenxue Ma: An Integrative Framework for Macrophage-Mediated Therapeutic Resistance in Cancer
-
Nov 8, 2026, 19:25Yildiz Yigit: Presenting a Polycythemia Vera Case at the MPN Subcommittee Session
-
Nov 8, 2026, 18:56Denis Oduor: Strengthening the Regulation and Delivery of Blood Transfusion and Transplantation Services
-
Nov 8, 2026, 18:28Raghavendra Rao: A Narrative Review on Chronic Venous Disease during Pregnancy
-
Nov 8, 2026, 17:57Dhiren Patel: PLD1-Derived Phospholipids Regulate NAD Kinase and ROS Production in Neutrophils
-
Nov 8, 2026, 17:48Andra T.: What Causes Antiphospholipid Syndrome? – Four Steps, not One Cause
-
Nov 8, 2026, 17:38Nasrin Samadi: Can a Normal Clotting Test Be Misleading?